Immuron (IMRN) Depreciation & Amortization - Total (2016 - 2018)
Immuron (IMRN) posted Depreciation & Amortization - Total of -$2646.0 for Q4 2018, down 51.1% on a QoQ basis from -$1751.1 in Q4 2017, and down 51.1% year-over-year from -$5411.6 in Q4 2017.
Analysis
Immuron (IMRN) Depreciation & Amortization - Total (2016 - 2018) Analysis & Trends
Immuron has reported Depreciation & Amortization - Total for 3 years, with the latest figure at -$2646.0 in Q4 2018.
- On a quarterly basis, Depreciation & Amortization - Total fell 51.1% year-over-year to -$2646.0 in Q4 2018; TTM through Dec 2018 was -$8792.4, a N/A change from a year earlier, with the FY2018 full-year figure at -$3842.3, down 2.46% from the prior year.
- Depreciation & Amortization - Total was -$2646.0 for Q4 2018 at Immuron, down from -$1751.1 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was -$1489.1 in Q4 2016, with the low at -$2906.2 in Q2 2016.
- Average Depreciation & Amortization - Total over 3 years is -$2198.1, with a median of -$2198.6 recorded in 2017.
- The sharpest annual moves came in 2017 and 2018: Depreciation & Amortization - Total decreased 17.59% in 2017, then plunged 51.1% in 2018.
- Over 3 years, Depreciation & Amortization - Total stood at -$1489.1 in 2016, then fell by 17.59% to -$1751.1 in 2017, then slumped by 51.1% to -$2646.0 in 2018.
- The last three Depreciation & Amortization - Total figures came in at -$2646.0 (Q4 2018), -$1751.1 (Q4 2017), and -$1489.1 (Q4 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Immuron | 10.53 Mn | 1.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -2,646.00 |
| Dec 31, 2017 | -1,751.10 |
| Dec 31, 2016 | -1,489.11 |
| Jun 30, 2016 | -2,906.17 |